RAND to Release Round 3 of Hospital Pricing Study This Week

AHA Member Advisory
September 16, 2020


This week, the RAND Corporation is slated to release Round 3 of its National Hospital Price Transparency Study, an employer-led initiative intended to measure and report publicly the prices paid for care at the hospital and service-line level. While we have not yet been able to review the document, we expect RAND to continue to make broad claims about pricing based on a limited sample of private health plan rates in selected states. The new version also may include additional self-funded plans and quality data from the Leapfrog group.

Sign In to Download the Member Advisory:
RAND to Release Round 3 of Hospital Pricing Study This Week

Related Resources

Letter/Comment
Public
Letter the AHA sent to Senators Grassley and Durbin in support of S. 2304, Drug-Price Transparency for Consumers Act of 2021. The bill will allow HHS to…
Advisory
Member
The hospital price transparency rule took effect Jan. 1, 2021. CMS verified for the AHA that the agency has begun proactive audits of hospital websites and a…
Letter/Comment
Member
AHA urges the Centers for Medicare & Medicaid Services to align the Hospital Price Transparency Rule with new transparency requirements included in the No…
Letter/Comment
Public
AHA letter urging HHS to exercise enforcement discretion with respect to the hospital price transparency rule.
Special Bulletin
Member
A federal appeals court today ruled against AHA’s legal challenge to the Centers for Medicare…
Advisory
Public
The hospital price transparency rule takes effect Jan. 1, 2021, requiring hospitals and health systems to disclose all standard charges, as defined by the…